Bio-Techne Corp (TECH) saw an uptrend of 2.11% in the recent trading with $2460000.0 being its most recent. The current price level -36.40% lower than the highest price of $83.62 marked by the stock while trading over the past 52-weeks, whereas it is 15.58% higher than the lowest price of $46.01 the company dropped to over past 52-weeks. The latest news story on TECH appeared in (Zacks) under the title “Bio-Techne’s New USP Deal on mAb and Gene Therapy May Boost Its Stock” on Jun-30-25.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 7 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.78 for the stock.
Bio-Techne Corp Earnings – What Happened With TECH
Coming around sales and income figures on TECH Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Bio-Techne Corp – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 156.76 million. TECH does have institutional investors; and they hold 104.66% of the stock.
As on 2024-06-30, VANGUARD GROUP INC was the top most holder in Bio-Techne Corp (NASDAQ:TECH) with an ownership of 18.18 million shares of the company or 11.5171 of the stake worth $1.3 billion. The filing also reveals BLACKROCK INC. as the second largest holder in the company with a control over 9.4939 of the outstanding shares. Its stake is worth $1.07 billion for having 14.99 million shares in hand.
PRICE T ROWE ASSOCIATES INC /MD/ also came holding a key position in the company during the recent quarter and it now holds 5.4006 of the outstanding shares. With this there are now 854.0 institutions which have possession in TECH’s shares.
Key Metrics forTECH
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Bio-Techne Corp has a debt to equity ratio of 0.21.
Technical Analysis of Bio-Techne Corp (NASDAQ:TECH) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Bio-Techne Corp (TECH), we notice that the stock’s 20-day average volume is at 2,220,200 shares. Medium term indicators at an average of 50% are spotting the stock at Sell with its 50-day average volume of 2,406,916 shares. And to end, TECH’s 100-day average volume is 2,230,454 shares with 100% of the long-term indicators pointing towards Sell for the stock.
